MedTrace Logo

Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

NCT01276834 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-08-07

No results posted yet for this study

Summary

To compare in a prospective randomised way the effect of two different immunosuppressive regimens - mTOR-based regimen or CNI-based regimen - on the progression of coronary artery calcification in renal transplant patients measured at baseline, 1, 2, and 3 years after transplantation.

Conditions

  • Renal Transplantation

Interventions

DRUG

everolimus

comparison of everolimus-based and CNI-based immunosuppression

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • Dianet Dialysis Centers

    lead OTHER

Principal Investigators

  • Franka E van Reekum, MD · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276834 on ClinicalTrials.gov